Association of interleukin 28B and mutations in the core and NS5A region of hepatitis C virus with response to peg-interferon and ribavirin therapy. [electronic resource]
Producer: 20120312Description: 1359-65 p. digitalISSN:- 1478-3231
- Aged
- Amino Acid Substitution
- Antiviral Agents -- therapeutic use
- Biopsy
- Chi-Square Distribution
- Drug Resistance, Viral -- genetics
- Drug Therapy, Combination
- Female
- Genotype
- Hepacivirus -- drug effects
- Hepatitis C, Chronic -- complications
- Humans
- Interferon alpha-2
- Interferon-alpha -- therapeutic use
- Interferons
- Interleukins -- genetics
- Japan
- Liver Cirrhosis -- drug therapy
- Logistic Models
- Male
- Middle Aged
- Mutation
- Patient Selection
- Phenotype
- Polyethylene Glycols -- therapeutic use
- Polymorphism, Single Nucleotide
- RNA, Viral -- blood
- Recombinant Proteins -- therapeutic use
- Ribavirin -- therapeutic use
- Risk Assessment
- Risk Factors
- Time Factors
- Treatment Outcome
- Viral Core Proteins -- genetics
- Viral Load
- Viral Nonstructural Proteins -- genetics
No physical items for this record
Publication Type: Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.